Results 171 to 180 of about 6,017,180 (335)

Governance frameworks and decision-making models for intensive care units in low- and middle-income countries: a scoping review protocol. [PDF]

BMJ Open
Ghoshal A, Damani A, Rao S, Varghese V C, Salins N.   +4 more
europepmc   +1 more source

Analyzing dynamic decision-making models using Chapman-Kolmogorov equations. [PDF]

J Comput Neurosci, 2019
Barendregt NW, Josić K, Kilpatrick ZP.
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Geostatistical and multi-criteria decision-making models to subsidize a quantitative monitoring network of aquifers intensively used for irrigated agriculture: the case of Urucuia Aquifer System, Brazil. [PDF]

Environ Monit Assess
Leão BRC, da Silva Junior GC, Marques EAG.   +2 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Comparing intertemporal decision-making models: Predictions and applications in lifespan through subjective time perception. [PDF]

Br J Psychol
Dai L, Wang Y, Chark R, Liu L.
europepmc   +1 more source

The use of multi-criteria decision making models in evaluating anesthesia method options in circumcision surgery. [PDF]

BMC Med Inform Decis Mak, 2017
Hancerliogullari G, Hancerliogullari KO, Koksalmis E.   +2 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Enhancing teacher recruitment and retention through decision-making models in education systems. [PDF]

Sci Rep
Liu T, Li W.
europepmc   +1 more source

Using Covert Response Activation to Test Latent Assumptions of Formal Decision-Making Models in Humans. [PDF]

J Neurosci, 2015
Servant M, White C, Montagnini A, Burle B.   +3 more
europepmc   +1 more source